Search Results - "Filomena Calabrese"

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol by Avallone, Antonio, Piccirillo, Maria Carmela, Di Gennaro, Elena, Romano, Carmela, Calabrese, Filomena, Roca, Maria Serena, Tatangelo, Fabiana, Granata, Vincenza, Cassata, Antonio, Cavalcanti, Ernesta, Maurea, Nicola, Maiolino, Piera, Silvestro, Lucrezia, De Stefano, Alfonso, Giuliani, Francesco, Rosati, Gerardo, Tamburini, Emiliano, Aprea, Pasquale, Vicario, Valeria, Nappi, Anna, Vitagliano, Carlo, Casaretti, Rossana, Leone, Alessandra, Petrillo, Antonella, Botti, Gerardo, Delrio, Paolo, Izzo, Francesco, Perrone, Francesco, Budillon, Alfredo

“…Background: Despite effective treatments, metastatic colorectal cancer (mCRC) prognosis is still poor, mostly in RAS-mutated tumors, thus suggesting the need…”
Get full text

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer by Cardone, Claudia, Martinelli, Erika, Troiani, Teresa, Sforza, Vincenzo, Avallone, Antonio, Nappi, Anna, Montesarchio, Vincenzo, Andreozzi, Francesca, Biglietto, Maria, Calabrese, Filomena, Bordonaro, Roberto, Cordio, Stefano, Bregni, Giacomo, Febbraro, Antonio, Garcia-Carbonero, Rocio, Feliu, Jaime, Cervantes, Andrés, Ciardiello, Fortunato

“…BackgroundIn patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC), the role of maintenance therapy after first-line treatment with chemotherapy…”
Get full text

MO234LIFE THREATENING MALIGNANT HYPERCALCEMIA IN BREAST CANCER: CAN THE NEPHROLOGIST CHANGE THE PATIENT DESTINY? by Pensabene, Matilde, Von Arx, Claudia, Giuliana, Sofia, Calabrese, Filomena, Capodanno, Paola, Piscopo, Anna Maria, Cavalcanti, Ernesta, Cuomo, Arturo, Capasso, Giovambattista, De Laurentiis, Michelino, Simeoni, Mariadelina

Get full text

Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment by Petrillo, Angelica, Pappalardo, Annalisa, Pompella, Luca, Tirino, Giuseppe, Calabrese, Filomena, Laterza, Maria Maddalena, Caterino, Marianna, Ventriglia, Anna, Orditura, Michele, Conzo, Giovanni, Molino, Carlo, Ciardiello, Fortunato, Biglietto, Maria, De Vita, Ferdinando

“…Nab-paclitaxel plus gemcitabine (Nab-Gem) represents one of the standard regimen for first-line treatment of metastatic pancreatic adenocarcinoma (mPDAC)…”
Get full text

First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age by Petrillo, Angelica, Pappalardo, Annalisa, Calabrese, Filomena, Tirino, Giuseppe, Pompella, Luca, Ventriglia, Jole, Laterza, Maria Maddalena, Caterino, Marianna, Sforza, Vincenzo, Iranzo, Vega, Biglietto, Maria, Orditura, Michele, Ciardiello, Fortunato, Conzo, Giovanni, Molino, Carlo, De Vita, Ferdinando

“…Nab-paclitaxel plus gemcitabine represents one of the standard regimens for first line treatment of metastatic pancreatic cancer (mPC). Few data are available…”
Get full text

Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial by Palmieri, Giovannella, Buonerba, Carlo, Ottaviano, Margaret, Federico, Piera, Calabrese, Filomena, Von Arx, Claudia, De Maio, Ana Paula, Marino, Mirella, Lalle, Maurizio, Montella, Liliana, Merola, Carmela, Milella, Michele, Bergaglio, Marina, Di Lorenzo, Giuseppe, Damiano, Vincenzo

“…A multi-institutional Phase II trial was initiated in 2005 to test the combination gemcitabine and capecitabine in patients with thymic epithelial malignancies…”
Get more information

A case series of low-dose sorafenib plus tamoxifen in sorafenib-pretreated patients with advanced hepatocellular carcinoma by Palmieri, Giovannella, Federico, Piera, Ottaviano, Margaret, Buonerba, Carlo, Calabrese, Filomena, Rescigno, Pasquale, De Maio, Anapaula, Micillo, Mariateresa, di Lorenzo, Giuseppe, Damiano, Vincenzo

“…Abstract only…”
Get full text

Capecitabine plus gemcitabine in thymic epithelial tumors: Final analysis of a phase II trial by Buonerba, Carlo, Ottaviano, Margaret, Federico, Piera, Calabrese, Filomena, Von Arx, Claudia, Iaccarino, Simona, Nappi, Lucia, Tucci, Irene, di Lorenzo, Giuseppe, Matano, Elide, Damiano, Vincenzo, Palmieri, Giovannella

“…Abstract only…”
Get full text

Capecitabine-gemcitabine in thymic epithelial tumors by Palmieri, Giovannella, Buonerba, Carlo, Di Lorenzo, Giuseppe, Federico, Piera, Nappi, Lucia, Rescigno, Pasquale, Calabrese, Filomena, Ottaviano, Margaret, De Placido, Sabino, Damiano, Vincenzo

“…Abstract only e18536 Background: Thymic epithelial tumors (TET) are a rare disease. Once loco-regional treatments have failed, platinum-based chemotherapy is…”
Get full text

Thymic epithelial tumors at University Federico II of Naples: A 30-year experience by Buonerba, Carlo, Federico, Piera, Calabrese, Filomena, Ottaviano, Margaret, Nappi, Lucia, Rescigno, Pasquale, Matano, Elide, Di Lorenzo, Giuseppe, Damiano, Vincenzo, Palmieri, Giovannella

“…Abstract only 7603 Background: According to the 2004 WHO classification, thymic epithelial tumors (TETs) comprise different histologies, including thymomas,…”
Get full text

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with -mutated metastatic colorectal cancer: the REVOLUTION study protocol by Antonio Avallone, Maria Carmela Piccirillo, Elena Di Gennaro, Carmela Romano, Filomena Calabrese, Maria Serena Roca, Fabiana Tatangelo, Vincenza Granata, Antonio Cassata, Ernesta Cavalcanti, Nicola Maurea, Piera Maiolino, Lucrezia Silvestro, Alfonso De Stefano, Francesco Giuliani, Gerardo Rosati, Emiliano Tamburini, Pasquale Aprea, Valeria Vicario, Anna Nappi, Carlo Vitagliano, Rossana Casaretti, Alessandra Leone, Antonella Petrillo, Gerardo Botti, Paolo Delrio, Francesco Izzo, Francesco Perrone, Alfredo Budillon

“…Background: Despite effective treatments, metastatic colorectal cancer (mCRC) prognosis is still poor, mostly in RAS -mutated tumors, thus suggesting the need…”
Get full text

Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor by Moretto, Roberto, Cella, Chiara A, Raimondo, Lucia, Formisano, Luigi, Nappi, Lucia, Rescigno, Pasquale, Buonerba, Carlo, Calabrese, Filomena, Ottaviano, Margaret, Di Lorenzo, Giuseppe, Matano, Elide, Damiano, Vincenzo, Palmieri, Giovannella

“…Tumor-to-tumor metastasis is a rare phenomenon, with around 150 cases being reported in the literature. Breast cancer is the second most commonly reported…”
Get full text

Leonardo's Literary Writings: History, Genre, Philosophy by Calabrese, Filomena

“…This dissertation examines Leonardo da Vinci’s literary writings, namely those known as the Bestiario, Favole, Facezie, and Profezia, as compelling expressions…”
Get full text

Leonardo's Literary Writings: History, Genre, Philosophy by Calabrese, Filomena

“…This dissertation examines Leonardo da Vinci's literary writings, namely those known as the Bestiario, Favole, Facezie, and Profezia, as compelling expressions…”
Get full text

Il “bestiario”: scienza e letteratura in leonardo da vinci by Calabrese, Filomena

“…Le Bestiaire de Léonard de Vinci (datable aux alentours de 1493-1494) est une œuvre qui s'inscrit dans le cadre de la complexe tradition…”
Get full text

Leonardo da Vinci and the Art of Sculpture by CALABRESE, FILOMENA

Get full text

Radke, Gary M. Leonardo da Vinci and the Art of Sculpture by Calabrese, Filomena

Get full text

Book Review: Interpretations of Renaissance Humanism by Calabrese, Filomena

Get full text

Leonardo da Vinci and the Art of Sculpture by Radke (book author), Gary M., Kemp (book contributor), Martin, Calabrese (review author), Filomena

Get full text